British Columbia-based patient advocacy group TheraPsil kicked off their latest campaign on Monday, asking Health Canada to establish regulations for safe and equitable medical access to psilocybin-assisted psychotherapy, and to provide timely responses to those applying for the treatment.
Share this post
